Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Statement

8 Jan 2009 07:00

RNS Number : 2994L
Persimmon PLC
08 January 2009
 



TRADING UPDATE - 8 JANUARY 2009

Persimmon plc announces the following trading update ahead of its Preliminary Results for the year ended 31 December 2008, which will be announced on Tuesday 3 March 2009.

Results for the full year will be in line with market expectations. We have legally completed 10,202 units at an average selling price of c. £172,000. This represents a turnover of c. £1.76 billion.

Our emphasis on cash control has resulted in a reduction of total borrowings at the year end to c. £600 million (June 2008: £906 million). As anticipated at the time of our Interim Results on 21 August 2008 we have generated good net cash inflow from operations through the second half of 2008. Close control of work in progress including the focus on sales of stock properties and over 50% reduction in part exchange holdings has resulted in this strong cash generation, despite the previously reported deterioration in trading conditions encountered from early September 2008. The year end borrowings are lower than originally anticipated due to the early receipt of tax repayment following the provisions announced in our Interim Management Statement on 27 October 2008.

Until there is an improvement in the restricted credit conditions currently experienced we will continue to focus on conserving cash. As a consequence the Board does not intend to pay a final dividend this year.

In addition, we have commenced discussions for the planned refinancing of the Group's credit facilities. Having made good progress, our bank syndicate and private placement investors are actively engaged in establishing facilities appropriate for the future needs of the business together with covenants reflective of current credit market conditions.

Whilst we believe that the long term future for the UK housing market remains good, the short term outlook is challenging. However, we currently have forward sales of c. £400 million.

Further details of the Group's performance for the year together with a general market update will be provided with the announcement of our Results for the year ended 31 December 2008, on Tuesday 3 March 2009.

For further information, please contact:

Persimmon plc

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

On 8 January 2009 +44 (0) 207 153 1533

Thereafter: +44 (0) 1904 642 199 

M: Communications

Edward Orlebar:  +44 (0) 207 153 1523 / +44 (0) 7738 724 630

Charlotte McMullen:  +44 (0) 207 153 1549 / +44 (0) 7921 881 800

Marylene Guernier  +44 (0) 207 153 1269 / +44 (0) 7776 303 788

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBRMRTMMIMBFL
Date   Source Headline
8th Dec 20203:50 pmRNSDirector/PDMR Shareholding
1st Dec 20203:22 pmRNSBlock listing Interim Review
1st Dec 20203:01 pmRNSTotal Voting Rights
25th Nov 202011:50 amRNSAdditional Listing
10th Nov 20207:00 amRNSThird Quarter Trading Statement
2nd Nov 20203:11 pmRNSTotal Voting Rights
27th Oct 20203:37 pmRNSAdditional Listing
16th Oct 202012:46 pmRNSGrant of SAYE Option
29th Sep 202012:27 pmRNSDirector/PDMR Shareholding
8th Sep 202010:25 amRNSNew Chief Executive Officer Start Date
1st Sep 20202:00 pmRNSTotal Voting Rights
28th Aug 20202:02 pmRNSDirector/PDMR Shareholding
26th Aug 20207:44 amRNSPersimmon Plc (PSN) - Additional Listing
19th Aug 20207:02 amRNSUpdate on Chief Executive Officer Appointment
18th Aug 20207:00 amRNSHalf Year Results
20th Jul 20201:49 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSTrading Update
1st Jul 202012:42 pmRNSTotal Voting Rights
29th Jun 20204:58 pmRNSAppointment of CEO
24th Jun 20207:00 amRNSAppointment of new Chief Executive Officer
8th Jun 20204:17 pmRNSDirectorate Change
5th Jun 202010:00 amRNSDirector/PDMR Shareholding
1st Jun 20202:05 pmRNSBlock listing Interim Review
1st Jun 20201:13 pmRNSTotal Voting Rights
26th May 20202:28 pmRNSDirector/PDMR Shareholding
20th May 20208:40 amRNSDirector Declaration
14th May 20207:00 amRNSCOVID-19 Update
1st May 20201:56 pmRNSTotal Voting Rights
29th Apr 20203:34 pmRNSResult of AGM
29th Apr 20207:01 amRNSBoard Change
29th Apr 20207:00 amRNSTrading Update
27th Apr 20204:32 pmRNSDisclosure of rights attached to equity shares
24th Apr 20207:00 amRNSCOVID-19 Update
3rd Apr 20209:16 amRNSDirector Declaration
2nd Apr 20206:14 pmRNSFurther Update on Covid-19 – Board Remuneration
1st Apr 20209:51 amRNSTotal Voting Rights
25th Mar 20207:00 amRNSCovid-19, Capital Return Plan and AGM Updates
17th Mar 20203:42 pmRNSAnnual Financial Report
16th Mar 20207:00 amRNSAppointment of Joint Corporate Broker
5th Mar 20204:47 pmRNSDirector/PDMR Shareholding
2nd Mar 202011:05 amRNSTotal Voting Rights
27th Feb 20207:00 amRNSCEO Succession
27th Feb 20207:00 amRNSFinal Results
17th Feb 20207:00 amRNSBoard Change
3rd Feb 202012:00 pmRNSTotal Voting Rights
15th Jan 20207:02 amRNSBoard Change
15th Jan 20207:00 amRNSTrading Update
2nd Jan 202011:01 amRNSTotal Voting Rights
2nd Dec 201912:45 pmRNSBlock listing Interim Review
18th Nov 20193:48 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.